World-First mRNA Vaccine For Skin Cancer Commences Landmark Phase 3 Trial

A UK man has become one of the first to receive an experimental mRNA vaccine designed to prevent recurrence of melanoma skin cancer. Steve Young, a 52-year-old musician, had a stage II melanoma removed previously, and said the shot is his “best chance” at stopping the cancer coming back. “I feel lucky to be part of this clinical trial,” Young said in a statement. This is Phase 3 of a trial process that has already seen encouraging results in human …